SCHEMBL2813982

SCHEMBL2813982

ClCCCn1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28907425 0.97 TP53 (0.39)
SCHEMBL537308 0.92 TP53 (0.39)
SCHEMBL536784 0.89 TP53 (0.37)
SCHEMBL2818039 0.89 TP53 (0.37)
SCHEMBL536275 0.81
SCHEMBL691481 0.81 TP53 (0.48)
SCHEMBL20465806 0.81 TP53 (0.48)
Hydrochloric Acid SCHEMBL6154472 0.79
SCHEMBL27458343 0.78 TP53 (0.46)
SCHEMBL27910344 0.73 TP53 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113354616-B Diaryl-1, 2, 4-triazole compound and preparation method and pharmaceutical application thereof 中国医学科学院药物研究所 2024-03-26 CN disclosed
CN-117285512-A 2, 5-diketopiperazine-imidazole compound, preparation method and application thereof 大连万众益生大健康有限公司 2023-12-26 CN disclosed
CN-113354616-A Diaryl-1, 2, 4-triazole compound, preparation method and pharmaceutical application thereof 中国医学科学院药物研究所 2021-09-07 CN disclosed
CN-110177786-A Pyrazolo [1,5-A] pyridine compounds being substituted are as RET kinase inhibitor 阿雷生物药品公司 2019-08-27 CN disclosed
CN-109153650-A Amine-substituted aryl or heteroaryl compounds as EHMT1 and EHMT2 inhibitors EPIZYME股份有限公司 2019-01-04 CN disclosed
CN-106117217-B A kind of preparation method of fluozirconate 南京远淑医药科技有限公司 2018-07-10 CN disclosed
EP-2414432-B1 AMINE-TERMINATED TELECHELIC POLYMERS AND PRECURSORS THERETO AND METHODS FOR THEIR PREPARATION CHEVRON ORONITE CO (US) 2017-05-31 EP disclosed
EP-3099685-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2016-12-07 EP disclosed
CN-106117217-A A kind of preparation method of fluozirconate 南京远淑医药科技有限公司 2016-11-16 CN disclosed
US-9315595-B2 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation CHEVRON ORONITE COMPANY LLC (US) 2016-04-19 US disclosed
WO-2015113990-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2015-08-06 WO disclosed
CN-102356114-B Amine-terminated telechelic polymers and precursors thereto and methods for their preparation CHEVRON ORONITE CO 2014-06-25 CN disclosed
US-20140031497-A1 AMINE-TERMINATED TELECHELIC POLYMERS AND PRECURSORS THERETO AND METHODS FOR THEIR PREPARATION THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2014-01-30 US disclosed
US-8552122-B2 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2013-10-08 US disclosed
CN-102356114-A Amine-terminated telechelic polymers and precursors thereto and methods for their preparation CHEVRON ORONITE CO 2012-02-15 CN disclosed
US-20100249001-A1 AMINE-TERMINATED TELECHELIC POLYMERS AND PRECURSORS THERETO AND METHODS FOR THEIR PREPARATION UNIVERSITY OF SOUTHERN MISSISSIPPI 2010-09-30 US disclosed
EP-2012791-A2 7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGS AS HSP90-INHIBITORS Conforma Therapeutics Corporation (US) 2009-01-14 EP disclosed
US-20070253896-A1 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2007-11-01 US disclosed
WO-2007092496-A2 7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2007-08-16 WO disclosed